Login / Signup

The Brazilian compound library (BraCoLi) database: a repository of chemical and biological information for drug design.

Gabriel Corrêa VeríssimoValtair Severino Dos Santos JúniorIngrid Ariela do Rosário de AlmeidaMarina Sant'Anna Mitraud RuasLukas Galuppo CoutinhoRenata Barbosa de OliveiraRicardo José AlvesVinícius Gonçalves Maltarollo
Published in: Molecular diversity (2022)
The Brazilian Compound Library (BraCoLi) is a novel open access and manually curated electronic library of compounds developed by Brazilian research groups to support further computer-aided drug design works, available on https://www.farmacia.ufmg.br/qf/downloads/ . Herein, the first version of the database is described comprising 1176 compounds. Also, the chemical diversity and drug-like profiles of BraCoLi were defined to analyze its chemical space. A significant amount of the compounds fitted Lipinski and Veber's rules, alongside other drug-likeness properties. A comparison using principal component analysis showed that BraCoLi is similar to other databases (FDA-approved drugs and NuBBE DB ) regarding structural and physicochemical patterns. Furthermore, a scaffold analysis showed that BraCoLi presents several privileged chemical skeletons with great diversity. Despite the similar distribution in the structural and physicochemical spaces, Tanimoto coefficient values indicated that compounds present in the BraCoLi are generally different from the two other databases, where they showed different kernel distributions and low similarity. These facts show an interesting innovative aspect, which is a desirable feature for novel drug design purposes.
Keyphrases
  • adverse drug
  • drug induced
  • machine learning
  • healthcare
  • computed tomography
  • minimally invasive
  • big data
  • artificial intelligence
  • social media
  • data analysis